Motif

Ending depression with brain-computer interfaces

Human 3 criteria:

Distribution shifting

Prior evidence of human use

Step change

Motif is making highly convenient, “TMS-to-go” by miniaturizing Transcranial Magnetic Stimulation into a tiny implant that is inserted in the skull (not the brain) in a 20-minute outpatient procedure. TMS is a highly effective treatment for depression, but normally requires 40+ doctors office visits. Motif aims to eliminate this burden and make TMS a convenient, “take home” experience.

Under the radar for now - more info soon.

2022

XEIA invests

2024

$19M Series A led by Arboretum

$19M Series A led by Arboretum

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC